When designing pediatric research, one size does not fit all. Simply adapting the adult clinical study protocol into its child-sized version will not be enough to gain IRB approval.
Research involving minors must prioritize the rights, safety, and welfare of its young participants, and the FDA has issued substantial regulations to ensure pediatric research is conducted safely and ethically. This informative webinar covered the regulatory landscape governing pediatric research in the U.S. and the critical role of the IRB in protecting children participating in research.
Presented by: Mitchell Parrish, JD, CIP
Mitchell Parrish, JD, CIP – Quorum Review Regulatory Attorney
Mitchell Parrish joined Quorum Review IRB in January 2010 as an Attorney in Quorum’s Regulatory Department. Prior to Quorum, Mr. Parrish worked as Regulatory Counsel for Western IRB and as a Regulatory Advisor to the National Cancer Institute’s Central IRB.
Mr. Parrish earned his Juris Doctor from the University of Oregon School of Law and is a member of the Washington State Bar, including the Health and Corporate Law sections. Additionally, Mr. Parrish is a member of the American Bar Association and is a Certified Institutional Review Board Professional (CIP).